Skip to main content
BrightFocus Foundation
  • BrightFocus.org
  • Molecular Neurodegeneration Journal
  • Apply for a Grant
  • Programs
    • Alzheimer's Disease Research
      • ADR Request For Proposals
      • For Current Awardees
      • ADR Alumni Network
      • Recently Funded
    • Macular Degeneration Research
      • MDR Request For Proposals
      • For Current Awardees
      • MDR Alumni Network
      • Recently Funded
    • National Glaucoma Research
      • NGR Request For Proposals
      • For Current Awardees
      • NGR Alumni Network
      • Recently Funded
  • Grant Search
  • Recently Funded
  • Alumni Network
  • Events and Conferences
BrightFocus Foundation
  • Programs
    • Alzheimer's Disease Research
      • ADR Request For Proposals
      • For Current Awardees
      • ADR Alumni Network
      • Recently Funded
    • Macular Degeneration Research
      • MDR Request For Proposals
      • For Current Awardees
      • MDR Alumni Network
      • Recently Funded
    • National Glaucoma Research
      • NGR Request For Proposals
      • For Current Awardees
      • NGR Alumni Network
      • Recently Funded
  • Grant Search
  • Recently Funded
  • Alumni Network
  • Events and Conferences
  • BrightFocus.org
  • Molecular Neurodegeneration Journal
  • Apply for a Grant

Macular Degeneration Research

Since 1999, Macular Degeneration Research (MDR) has awarded nearly $46 million to support research into the causes and potential prevention strategies and treatments of macular degeneration disease. MDR is currently supporting 58 biomedical researcher projects.

Aparna Lakkaraju, PhD viewing an image on her computer monitor.
Request for Proposal

Highlights

A background image of science vials with overlying text that says US Food and Drug Administration.

BrightFocus Lauds FDA Approval of New Alzheimer’s Drug

Ilyas Washington, PhD

FDA Gives “Breakthrough” Status to Potential New Treatment for Vision Disease

A photomicrograph of cone shedding.

Looking for Age-Related Metabolic Changes in the Eye that Contribute to AMD

A retina with geographic atrophy and drusen.

Targeting Drusen Production in the AMD Retina

A retinal photo showing geographic atrophy.

New Hope for Geographic Atrophy, Says BrightFocus Chat Speaker

A female researcher working in the lab with pipette.

Macular Fast Track

Apply to Current RFP
For Current Awardees
Scientist Profiles
List of Grants

Yearbooks

2021 MDR Grants Yearbook
2020 MDR Grants Yearbook
2019 MDR Grants Yearbook
2018 MDR Grants Yearbook
2017 MDR Grants Yearbook
2016 MDR Grants Yearbook

Categories

Early AMD
Geographic Atrophy
Cellular Metabolism
Drusen Formation
Immune Response
Genetics
Diet and Nutrition
Wet AMD/Exudative AMD/ Neovascular AMD
Diagnostics
Innovative Approaches

Grants Notification

Site Footer

BrightFocus Foundation

BrightFocus Foundation

22512 Gateway Center Drive

Clarksburg, MD 20871

 

Phone: 1.800.437.2423

Fax: 301.258.9454

Email: researchgrants@brightfocus.org

  • Alzheimer's Disease Research
  • Macular Degeneration Research
  • National Glaucoma Research
  • Apply for a Grant
  • Recently Funded
  • Grant Search
  • Alumni Network
  • Contact Us
  • Molecular Neurodegeneration Journal
  • Events & Conferences
  • Frequently Asked Questions
  • Intellectual Property Policy

BrightFocus is a tax-exempt nonprofit organization under section 501(c)(3) of the Internal Revenue Code of the United States.

Copyright 2000 - 2020 BrightFocus Foundation. All rights reserved.

The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.

These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.

Some of the content may be adapted from other sources, which will be clearly identified within the article.

  • Legal Information
  • Do Not Sell My Info
  • Accountability
  • For Financial Advisors
  • Privacy Information